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Objective To investigate the relationship between disturbed lung function and large-artery hemodynamics in
school-age children born extremely preterm (EP) (at 25 completed weeks of gestation or less).
Study design This was a cross-sectional study of participants from the EPICure study, now aged 11 years (n =
66), and 86 age- and sex-matched term-born classmates. Spirometry parameters (including forced expiratory vol-
ume in 1 second), blood pressure, and augmentation index (AIx, a composite of arterial stiffness and global wave
reflections) were measured.
Results Compared with their classmates, the EP children had significantly impaired lung function, particularly
those with neonatal bronchopulmonary dysplasia. Peripheral blood pressure did not differ significantly between
the 2 groups, but AIx values were on average 5% higher (95% CI, 2%-8%) in the preterm infants, remaining signif-
icant after adjustment for potential confounders. Neonatal bronchopulmonary dysplasia status was not related to
AIx. Lung function and maternal smoking were independently associated with AIx; AIx increased by 2.7% per
z-score reduction in baseline forced expiratory volume in 1 second and by 4.9% in those whose mothers smoked
during pregnancy.
Conclusion The independent association between impaired lung function and cardiovascular physiology in
early adolescence implies higher cardiovascular risk for children born EP, and suggests that prevention of
chronic neonatal lung disease may be a priority in reducing later cardiovascular risk in preterm infants. (J Pediatr
2012;161:595-601).
A
longside a number of traditional risk factors, disturbed lung function has emerged as a key independent risk factor
for cardiovascular disease in adults.1,2 Recent work has identified the independent, indirect relationship between lung
function and arterial stiffness, itself an independent cardiovascular predictor,3 in adults with chronic respiratory dis-
eases, such as chronic obstructive pulmonary disease (COPD)4,5 and cystic fibrosis, as well as in an unselected population of
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Nottingham (ending September 2008) and subsequently
by University College London. A list of EPICure StudiesImpaired lung function has repeatedly been demonstrated in children born
very preterm, independent of chronic neonatal lung disease or bronchopulmo-
nary dysplasia (BPD).8 Both structural and functional impairments in lung func-
tion appear to persist into adulthood.9-11 The implications of preterm birth are of
increasing relevance to adult physicians, given improved survival,12 tracking of
lung function throughout life,13-15 and concerns that the normal age-related de-
cline in lung function may be accelerated in such individuals.16 There is growing
concern regarding the long-term effects of adverse early life events, including fe-
tal programming, along with altered prenatal and postnatal growth patterns,
which have been implicated in systolic hypertension and cardiovascular dis-
ease.17,18
The EPICure study identified significantly reduced lung function but nor-
mal brachial blood pressure (BP) in 6-year-old children born at 25 weeksSteering Committee members is available at www.jpeds.
com (Appendix).
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AIx Augmentation index
BP Blood pressure
BPD Bronchopulmonary dysplasia
COPD Chronic obstructive pulmonary disease
EP Extremely preterm
FEF25-75 Forced mid-expiratory flow
FEV1 Forced expiratory volume in 1 second
FVC Forced vital capacity
MAP Mean arterial pressure
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Ireland compared with national standards and class-
mates.19,20 Brachial BP traditionally has been used to assess
hemodynamic status, because of its ease and ready accessi-
bility. However, BP varies throughout the arterial tree due
to variations in arterial compliance and augmentation by
wave reflections; thus, peripheral BP measurements might
mask altered central hemodynamics.3 Vascular properties
are susceptible to change, promoting stiffness and increased
wave reflection from the peripheries. Central hemodynam-
ics were not measured in the children at 6 years of age in
the EPICure study.
Several previous studies have explored the association of
arterial stiffness and birth weight21-24; however, other studies
have found inconsistent findings or have not demonstrated
this association.25,26 Those studies focused on intrauterine
growth restriction as opposed to prematurity. Central hemo-
dynamics were measured at 11 years of age in the EPICure
study. We have reported that the augmentation index
(AIx), a composite vascular parameter of arterial stiffness
and global peripheral wave reflection, is increased in children
born extremely preterm (EP) compared with classmates.3,27
In younger individuals, AIx is more closely related to cardio-
vascular risk factors compared with more direct measures of
large artery stiffening, such as aortic pulse wave velocity, the
speed of pulsation down the aorta between the carotid and
femoral pulsations, an independent predictor of cardiovascu-
lar disease in older adult subjects.3,28
Given the known impaired lung function in this popula-
tion,29 we hypothesized that functional impairment would
parallel altered central hemodynamics at age 11 years in chil-
dren born EP. If so, then strategies to protect lung function
during the neonatal period may have further important addi-
tional benefits for cardiovascular physiology and in limiting
cardiovascular disease in later life.
Methods
EPICure is a population-based study of all births between
March and December 1995 in the United Kingdom and Re-
public of Ireland, born at 25 completed weeks of gestation or
less (the data-sharing policy is available from www.epicure.
ac.uk). Details of the cohort ascertainment and progress
have been reported elsewhere.19,20 The current investigation
was part of an extensive assessment of this cohort at age 11
years comprising neurocognitive, respiratory, and other out-
comes.29-33Measurements were performed in school by 1 of 3
specially trained pediatricians. Schools were asked to identify
up to 3 classmates as potential comparisons, matched for age,
sex, and ethnic origin, 1 of whomwas selected at random.29,30
Classmates were excluded if born at <37 weeks gestational
age, hospitalized for respiratory complaint or had sustained
tuberculosis, pneumonia, or whooping cough. Asthma and
atopy were not exclusion criteria. The study protocol was ap-
proved by the Southampton and South West Hampshire Re-
search Ethics Committee. All parents gave written consent,
and the children provided verbal agreement.596Parents were contacted before the assessment to verify that
their child was well and free from any respiratory tract infec-
tions to ensure thatmeasurements were obtained during a pe-
riod of clinical stability. All bronchodilators and leukotriene
antagonists were withheld on the day of testing.
Standard Clinical Assessment
Weight was measured to the nearest 0.1 kg on a digital scale
(BWB 600; Tanita, Tokyo, Japan), with the child wearing
minimal clothing and barefoot. Height was recorded with
the child barefoot to the nearest 0.1 cm using a Leicester sta-
diometer (CrawleaMedical, Birmingham, United Kingdom).
Height and weight were converted to z-scores to adjust
for sex and age.34 Questionnaires eliciting information on
perinatal history, current health, therapies, and maternal
smoking were completed by parents.
Hemodynamic Assessment
The ability to include hemodynamic assessments in the pro-
tocol became available only during the latter part of the data
collection period. After extensive training, a single pediatri-
cian (J.F.) performed these measurements in children tested
from September 2006 onward, at 1 hour after spirometric
testing. After supine peripheral BP measurement (Omron,
Kyoto, Japan) as the mean of 3 consecutive brachial artery
readings, radial artery waveforms were recorded using
a high-fidelity micromanometer (Millar Instruments, Hous-
ton, Texas). Pulse-wave analysis (Sphygmocor; AtCor Medi-
cal, Sydney, Australia) was used to generate a corresponding
central waveform through a validated transfer function.35
The AIx is defined as the difference between the second
and first systolic peaks, expressed as a percentage of pulse
pressure.27 Pulse pressure amplification was calculated as
the ratio of peripheral pulse pressure to central pulse pres-
sure. Carotid-femoral (aortic) pulse wave velocity was mea-
sured as described previously,27 with results expressed as
the mean of duplicate readings from traces reviewed and se-
lected for quality by an independent experienced operator
(C.M.) blinded to birth status.
Lung Function Assessment
Baseline spirometry (Jaeger Masterscope V4.6; CareFusion,
Wurzberg, Germany) was performed according to published
guidelines.29 Consenting subjects were retested after admin-
istration of salbutamol 200 mg via a spacer device. A positive
bronchodilator response was defined as a >12% increase in
forced expiratory volume in 1 second (FEV1). All data were
sent to the University College London, Institute of Child
Health for centralized analysis and quality control by respira-
tory physiologists, blinded to the children’s birth status.29 Re-
sults were expressed as z-scores to adjust for sex, age, and
height.36
Statistical Analyses
Data from lung function and hemodynamic assessments were
combined with the main EPICure database for analysis. For-
ward stepwise regression was used to identify independentBolton et al
October 2012 ORIGINAL ARTICLESeffects on AIx; predictors considered were standardized mea-
sures of lung function, sex, birth status, BPD (defined as re-
ceiving supplemental oxygen at 36 weeks postmenstrual
age), maternal smoking during pregnancy, heart rate, mean
arterial pressure (MAP), age, and height at time of test, in ad-
dition to their interactions with EP status. AIx values are
based on unadjusted data. A P value <.05 was considered to
indicate statistical significance. Analyses were performed us-
ing SPSS version 11.0 (SPSS Inc, Chicago, Illinois) and Stata
release 10.1 (StataCorp, College Station, Texas).
Results
Of the 307 EPICure survivors known to be alive at age 11
years, 11 were abroad, 20 refused participation in this study,
and 57 were nonresponders. Valid spirometry data were ob-
tained from 187 of the 219 children (85%) whose parents
consented to the study, 66 (35%) of whom (including
45 [68%] with previous BPD) also underwent hemodynamic
assessment. Of 170 classmate controls contacted, 161 pro-
duced valid spirometry data, of whom 86 (53%) also had
data from hemodynamic studies. Characteristics of the study
subjects are presented in Table I. The subgroup of EPICure
children who underwent hemodynamic assessment was
representative of the entire cohort tested in school29 with
respect to neonatal history, respiratory morbidity,
maternal characteristics, and lung function testing results
(Table II; available at www.jpeds.com), but were slightly
older, reflecting their evaluation toward the end of the
recruitment period.
Hemodynamic Assessment
Peripheral diastolic BP and MAP were marginally higher in
the EP children compared with their classmates (mean differ-
ence, 2.1mmHg [95%CI,0.1 to 4.3mmHg] and 2.1mmHgTable I. Demographic data of the EP children and classmate
EP with BPD
(n = 45)
EP wit
(n
Gestational age, weeks 24.8 (0.8) 25
Birth weight, kg 0.73 (0.13) 0.7
Birth weight z-score* 0.26 (0.69) 0.0
Male sex, n (%) 24 (53)
Smoking in pregnancy n/N (%) 9/36 (23) 4 /1
White ethnicity, n/N (%) 27/35 (77) 1
Maternal nonmanual occupation, n/N (%) 18/30 (60) 9/1
Maternal continuing education after 16 years, n/N (%) 15/36 (42) 9/2
At time of assessment
Age, years 11.3 (0.5) 11
Height, cm 141.6 (7.5) 141
Height z-score* 0.55 (1.00) 0.6
Weight, kg 36.3 (7.9) 35
Weight z-score* 0.24 (1.13) 0.4
Current asthma, n/N (%) 8/37 (22) 6/2
Data are presented as mean (SD) unless noted otherwise. Current asthma is defined as currently
12 months. Not all subjects reported by McEniery et al27 with hemodynamic data (68 EP children a
controls form the basis of this report. Note that accurate gestational age and birth weight data wer
*Derived from Cole et al.34
†P < .001 between all EP children and control classmates.
zP < .01 between all EP children and control classmates.
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Preterm Birth[95% CI, 0.1 to 4.2 mmHg], respectively; both P = .06),
whereas peripheral pulse pressure was 3.6 mmHg (95%
CI, 6.6 to 0.6) lower (P < .05) (Table III; available at
www.jpeds.com). AIx was significantly (P < .001) higher in
the EP children (7%  10% vs 2%  9%: difference, 5%
[95% CI, 2%-8%]) and remained so after adjustment for
age, sex, MAP, and height (adjusted difference, 4% [95%
CI, 0.4%-7%]). Only a minimal difference in AIx was
detected between EP children with previous BPD and those
without BPD unadjusted difference [BPD  no BPD], 1%
[94% CI, 4 to 6]; adjusted difference, 2% (95% CI, 4%
to 7%). No relationship between AIx and gestational age or
birth weight was identified in the EP children. Pulse
pressure amplification was lower in the EP children than
their classmates, and aortic pulse wave velocity was similar
in the 2 groups. The AIx was lower in boys than in girls in
the EP group, but this sex difference was not evident in the
classmates, and there was no significant interaction between
sex and EP status (P = .50).Lung Function
Even after correction for height, age, and sex using stan-
dardized z-scores, children born EP had significantly worse
baseline lung function (difference in z-scores: FEV1, 1.02
[95% CI, 1.37 to 0.66]; forced vital capacity [FVC],
0.49 [95% CI, 0.83 to 0.15]; FEV1/FVC ratio, 0.79
[95% CI, 1.13 to 0.44]; forced mid-expiratory flow
[FEF25-75] 1.19 [95% CI, 1.57 to 0.81]) compared
with their classmates, with these differences most marked
in those with previous BPD (Table III). A positive
bronchodilator response was observed more frequently in
the EP children than in classmates (36% vs 9%), but
postbronchodilator FEV1 was significantly lower in the
EP children, indicating some degree of fixed airway
obstruction. Current or previous (within 12 months) usecontrols
hout BPD
=21)
All EP
(n = 66)
Controls (C)
(n = 86)
Mean (95% CI)
difference (EPC)
.0 (0.7) 24.9 (0.8) All >37 weeks
8 (0.12) 0.74 (0.13)
8 (0.90) 0.15 (0.77)
8 (38) 32 (48) 38 (45) 3% (13% to 19%)
9 (21) 13/55 (24) 9/78 (12) 12% (1% to 25%)
8 (86) 45/56 (80) 59/69 (86) 5% (18% to 8%)
8 (50) 27/48 (56) 42/70 (60) 4% (22% to 14%)
0 (45) 24/56 (42) 37/75 (49) 6% (24% to 11%)
.3 (0.6) 11.3 (0.5) 11.3 (0.6) 0.0 (0.2 to 0.2)
.3 (6.8) 141.5 (7.2) 147.1 (7.6) 5.6 (8.0 to 3.2)†
4 (0.90) 0.58 (0.97) 0.25 (1.03) 0.83 (1.15 to 0.50)z
.4 (7.0) 36.0 (7.6) 40.0 (9.7) 4.0 (6.8 to 1.2)z
0 (1.10) 0.29 (1.12) 0.26 (1.15) 0.54 (0.91 to 0.18)z
0 (30) 14/57 (25) 11/ 82 (13) 12% (1% to 26%)
symptomatic and/or with doctor diagnosis of asthma and on medication during the previous
nd 90 controls) had valid spirometry data; thus, the results from 66 children born EP and 86
e not available for controls.
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(A) (B)
Figure. Relationship of A, AIx to FEV1 z-score and B, reversibility of FEV1 (change >12%) in 11-year-old children born at #25
weeks gestation (EPICure) and control classmates. REV+, significant reversibility; REV, no significant reversibility.
Table IV. Results of stepwise multiple regression
analysis with AIx as the dependent variable and
including either FEV1 z-score or percent change in FEV1
after bronchodilator use
B 95% CI
Adjusted
r2, %
All subjects
FEV1 z-score
Constant 20.6 10.1 to 31.1
FEV1 z-score 2.7 3.9 to 1.5 10.6
Heart rate, bpm 0.2 0.4 to 0.1 16.9
Mother smoked during pregnancy 4.9 1.0 to 8.8 20.1
Percent change in FEV1 after
bronchodilator use
Constant 15.2 4.0 to 26.4
FEV1% change 0.5 0.3 to 0.7 14.1
Heart rate, bpm 0.2 0.31 to 0.1 18.1
Mother smoked during pregnancy 5.2 1.2 to 9.3 21.9
EP children alone*
FEV1 z-score
†
Constant 23.7 5.4 to 41.9
FEV1 z-score 2.2 4.2 to 0.2 8.7
Heart rate, bpm 0.2 0.4 to 0.01 14.4
Percent change in FEV1 after
bronchodilator usez
Constant 22.0 3.6 to 40.5
FEV1 % change 0.4 0.1 to 0.7 14
Heart rate, bpm 0.2 0.4 to 0.01 19.9
B, B test; bpm, beats per minute.
Variables entered in all models: age at testing (years), MAP (mmHg), heart rate (bpm), height
(cm), sex (male/female), BPD status (yes/no), maternal smoking during pregnancy (yes/no), and
EP (yes/no).
*Although smoking in pregnancy was not significant in these models, it had the same effect size
as in the whole cohort.
†B = 5.0; 95% CI, 0.7 to 10.7.
zB = 4.8; 95% CI, 1.0 to 10.6.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 161, No. 4of bronchodilators, inhaled corticosteroids, and leukotriene
antagonists was more common in the EP children (data
not shown).
Relationship of Lung Function and Hemodynamic
Parameters
In the EP children, AIx was inversely related to baseline lung
function (FEV1 z-score, r = 0.31; FEV1/FVC z-score, r =
0.31; FEF25-75 z-score, r =0.33), and directly proportional
to the percentage change in FEV1 after bronchodilator use
(r = 0.36; P < .01 for all comparisons) (Figure). In
contrast, in the classmate controls, AIx was correlated only
with FEF25-75 (r = 0.23; P < .05) and percent change in
FEV1 after bronchodilator use (r = 0.28; P = .01). Pulse
pressure amplification was related to FEV1/FVC ratio in
both EP children (r = 0.25; P = .04) and their classmates
(r = 0.25; P = .02). MAP, diastolic BP, and systolic BP were
not related to lung function measurements in the EP
children or classmates.
On multiple regression analysis, in all subjects, AIx was in-
dependently and inversely associated with baseline lung func-
tion, with a 2.7% increase in AIx for each z-score decrease in
FEV1 (Table IV). There was an additional affect of maternal
smoking during pregnancy, associated with a 4.9% increase
in AIx. Given that maternal smoke exposure was not
recorded in all subjects (Table I), the model was also run
without this variable; a similar association between baseline
FEV1 z-score and AIx was observed (data not shown).
Similar findings were observed when FEV1/FVC and
FEF25-75 were substituted for FEV1 in themodel. In the model
including baseline FEV1, there was no significant additional
contribution of percent change in FEV1 after bronchodilator
use, because of the strong inverse relationship between these
outcomes.However, using percent change in FEV1 after bron-
chodilator use instead of FEV1 in themodel, a 2.5% increase in598AIx for each 5% increase in FEV1 after bronchodilator use was
seen, with an additional 5.2% increase in AIx if the mother
had smoked during pregnancy. EP birth, previous BPD, and
current asthma did not contribute further to the model.Bolton et al
October 2012 ORIGINAL ARTICLESIn models restricted to EP children alone, baseline FEV1 or
percent change in FEV1 with bronchodilator use had similar
effects as in the whole group (Table IV). Although maternal
smoking in pregnancy was no longer significant (presumably
because of the smaller sample size and thus the lower power
of the study during subgroup analysis), it had the same size
effect as in the whole group. BPD status had no statistically
independent effect on AIx in these models.
Discussion
We have demonstrated that the increased pulse wave reflec-
tion, manifested as an increased AIx value, is independently
associated with impaired lung function in children born at
25 weeks of gestation or less compared with term-born class-
mates at age 11 years. Importantly, these abnormal large-
vessel hemodynamics are not reflected in peripheral BP, the
standard method of assessing hemodynamics at this age,
and no association was seen between lung function and pe-
ripheral BP. This novel association is relevant to both pediat-
ric and adult practice as increasing numbers of EP children
are reaching adulthood and must be considered at increased
risk for later cardiorespiratory morbidity based on these ob-
servations.
AIx not only was inversely related to baseline lung func-
tion, but also had independent associations with bronchodi-
lator response and maternal smoking during pregnancy.
Once these factors had been accounted for, whether or not
there is any further detrimental effect of preterm birth over
and above that manifested through the poor respiratory
function is uncertain. When multiple regression analysis
was limited to the children born EP, a striking independent
effect of lung function remained evident in this population.
EP birth is followed by significant respiratory and nutri-
tional problems, which lead to poor respiratory health and
growth during early childhood.10,19,20 Integral to the preterm
birth event and the consequent early abrupt changes to fetal
oxygenation and hemodynamics are the maternal or fetal fac-
tors contributing to the preterm birth, as well as the associ-
ated perinatal events such as the use of supplemental
oxygen or ventilator-induced lung injury. These factors fur-
ther complicate the search for specific causal pathways of re-
spiratory and cardiovascular risks. Thus, mechanisms remain
speculative, but are known to include a common develop-
mental pathway. Our data clearly demonstrate that we can
no longer consider the cardiovascular or respiratory sequelae
in isolation if we are to research how to optimize health fol-
lowing preterm birth.
Lung distensibility and elastic recoil are governed primar-
ily by the size of alveoli and surface tension in the healthy
lung, but elastin and collagen contribute as well. The alveolar
ducts contain a spiral of collagen and elastin, and the intersti-
tium contains bundles of collagen surrounding electron-
dense elastin. Within the aorta, elastin contributes
40%-50% of the dry weight in healthy subjects.37 Because de-
position of elastin within the aorta and in the respiratory
tract occurs late in gestation, it may be disrupted afterThe EPICure Study: Association between Hemodynamics and L
Preterm Birthpreterm birth and may influence both large arterial wall
and lung composition. However, the increase in AIx value as-
sociated with increased wave reflection suggests that a struc-
tural contribution to the abnormalities might involve the
elastic arteries juxtaposing the more muscular resistant
peripheral arteries or the microvasculature.
Alterations in angiogenic factors related to preterm birth,
such as disruption of vascular endothelial growth factor
and vascular/nitric oxide signaling, can lead to structural
changes of the cardiorespiratory system.38,39 The role of in-
flammatory changes in the genesis of preterm birth and the
evolution of neonatal lung disease and brain injury is a matter
of much debate.40 Although systemic inflammatory media-
tors are thought to contribute to the association between re-
duced lung function and increased arterial stiffness in both
healthy and ill adults, there is little causal evidence to confirm
this.4 It may be hypothesized that lung epithelial injury po-
tentiates a systemic inflammatory state, which in turn leads
to endothelial dysfunction or architectural disruption of
large arteries.41
Maternal smoking during pregnancy increases fetal nico-
tine exposure and is likely to affect both lung function and
arterial stiffness, as passive and direct smoking do in later
life.42 Increased fetal carboxyhemoglobin leads to hypoxemia
and, in murine models, increased oxidative stress when ex-
posed to smoke during the neonatal period.43 Supporting
this finding are altered hemodynamics in utero and in chil-
dren whose mothers smoked.44,45 Importantly, in this study,
the negative impact of maternal smoking on AIx was in addi-
tion to that attributed to reduced lung function.
The fetal and perinatal periods are times of rapid growth
and development with increased vulnerability to a wide range
of insults. Although few insults in the perinatal period com-
pare with that of being born EP, the potential impact of early
life exposures for other cardiorespiratory conditions can be
illuminating. Despite the clear association between COPD
and cumulative tobacco smoke exposure, there is marked
heterogeneity of COPD phenotypes and susceptibility, re-
lated not only to genetic susceptibility, but also to early life
exposures.46 Thus, although the altered hemodynamics re-
ported in adults with chronic lung diseases such as COPD
and cystic fibrosis have been attributed to an accelerated age-
ing of the vasculature, these physiological changes may orig-
inate in and be triggered by early life factors.
It should be noted that this study is cross-sectional in na-
ture, and any causal relationship can only be inferred. How-
ever, the EPICure study provides the opportunity to track
cardiorespiratory status and determine future consequences.
Further, this work is intended to challenge our current think-
ing of considering each system in isolation. AIx was based on
aortic pressure waveform data, derived from radial pressure
recordings, using a generalized transfer function that has
not been validated in children. However, McEniery et al18 re-
ported similar findings in this group with radial AIx, which
does not rely on this transfer function. We did not have de-
tailed data on family history of cardiovascular disease or on
cardiovascular status, patent ductus arteriosus, or pulmonaryung Function at 11 Years after Extremely 599
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 161, No. 4hypertension in infancy. Our findings raise the question of
whether a detailed evaluation of neonatal cardiovascular
findings, complications, and treatments now requires study
of the ontogeny of cardiovascular impairment in EP children
and the extent to which treatments for BPD and cardiovascu-
lar problems may modify adult outcomes across systems.
In conclusion, the increased AIx values found at age 11
years in EP children are inversely related to baseline lung
function and directly related to bronchodilator response,
with an additive contribution from exposure to maternal
smoking during fetal development. Children born EP who
are at increased risk for future cardiovascular and pulmonary
problems as adults have alterations suring childhood that are
not reflected in traditional measures of peripheral BP. n
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Table II. Comparison of study population and cohort of EP children tested at school at approximately 11 years of age
EP without
hemodynamics (n = 121)
EP with
hemodynamics (n = 66)
Mean (95% CI) of
difference (ba)
Male sex, n (%) 48/121 (40) 32/66 (48) 8% (6% to 22%)
White ethnicity, n/N (%) 92/114 (81) 45/56 (80) 1% (14% to 11%)
Gestational age, weeks 25.0 (0.8) 24.9 (0.8) 0.17 (0.39 to 0.05)
Birth weight, kg 0.75 (0.11) 0.74 (0.13) 0.01 (0.05 to 0.03)
Birth weight z-score 0.15 (0.76) 0.15 (0.77) 0.01 (0.23 to 0.24)
BPD, n/N (%) 87/121 (72) 45/66 (68) 4% (18% to 9%)
Smoking in pregnancy, n/N (%) 30/113 (27) 13/55 (24) 3% (17% to 11%)
Details at time of test
Age, years 10.9 (0.4) 11.3 (0.5) 0.4 (0.3 to 0.5)*
Height z-score 0.57 (1.03) 0.58 (0.97) 0.01 (0.31 to 0.30)
Weight z-score 0.60 (1.35) 0.29 (1.12) 0.32 (0.07 to 0.70)
Current asthma, n/N (%) 30/117 (26) 14/57 (25) 1% (14% to 13%)
FEV1 z-score 1.54 (1.2) 1.25 (1.2) 0.30 (0.06 to 0.66)
Data are mean (SD) unless noted otherwise.
*P < .01.
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Table III. Comparison of hemodynamic and lung function values in children born EP, with and without BPD, and
control classmates
EP with BPD
(n = 45)
EP, no BPD
(n = 21)
All EP
(n = 66)
Controls
(n = 86)
Mean (95% CI)
difference (EPcontrols)
Cardiovascular
Heart rate, bpm 82.5 (11.8) 81.1 (10.6) 82.0 (11.4) 79.6 (11.2) 2.4 (1.2 to 6.0)
Peripheral systolic BP, mmHg 107.6 (10.9) 109.7 (8.9) 108.2 (10.3) 109.7 (9.2) 1.5 (4.6 to 1.6)
Peripheral diastolic BP, mmHg 64.6 (7.3) 65.2 (5.2) 64.8 (6.7) 62.7 (7.1) 2.1 (0.1 to 4.3)
Peripheral MAP, mmHg 79.4 (7.0) 80.0 (5.6) 79.6 (6.6) 77.6 (6.7) 2.1 (0.1 to 4.2)
Peripheral pulse pressure, mmHg 43.0 (10.7) 44.5 (7.8) 43.5 (9.8) 47.1 (8.7) 3.6 (6.6 to 0.6)*
Central systolic BP, mmHg 92.3 (7.3) 93.7 (7.5) 92.7 (7.3) 91.4 (7.2) 1.4 (1.0 to 3.7)
Central diastolic BP, mmHg 66.2 (7.5) 66.6 (5.1) 66.3 (6.8) 64.1 (7.1) 2.2 (0.1 to 4.4)
Central pulse pressure, mmHg 26.1 (5.5) 27.1 (6.2) 26.5 (5.7) 27.2 (5.4) 0.8 (2.6 to 1.0)
AIx, % 8 (9) 7 (11) 7 (10) 2 (9) 5 (2 to 8)†
Aortic pulse wave velocity, m/s 4.5 (0.5) 4.5 (0.6) 4.5 (0.5) 4.7 (0.9) 0.21 (0.46 to 0.03)
Pulse pressure amplification 1.65 (0.27) 1.66 (0.15) 1.66 (0.24) 1.74 (0.11) 0.08 (0.14 to 0.02)z
Lung function
Respiratory rate, breaths/minute 19.1 (3.0) 19.3 (3.0) 19.2 (3.0) 17.7 (2.9) 1.5 (0.5 to 2.4)z
FEV1 z-score
x 1.54 (1.11) 0.63 (1.20) 1.25 (1.21) 0.23 (1.00) 1.02 (1.37 to 0.66)z
% of predicted 82.1 (12.8) 92.7 (14.1) 85.5 (14.0) 97.3 (11.7) 11.80 (15.94 to 7.68)z
FVC z-scorex 0.89 (1.14) 0.41 (1.16) 0.74 (1.16) 0.25 (0.95) 0.49 (0.83 to 0.15)z
% of predicted 90.2 (12.4) 95.5 (13.1) 91.9 (12.8) 97.2 (10.5) 5.31 (9.05 to 1.58)z
FEV1/FVC z-score
x 1.14 (1.09) 0.38 (1.30) 0.90 (1.21) 0.11 (0.9) 0.79 (1.13 to 0.44)z
FEF25-75 z-score
x 2.04 (1.12) 1.03 (1.37) 1.72 (1.29) 0.53 (1.07) 1.19 (1.57 to 0.81)z
% change in FEV1 with bronchodilator use
{,k 11 (13) 7 (10) 9 (11) 3 (5) 5 (3 to 8)z
Increase in FEV1 >12%, n (%)
{ 18 (43%) 3 (18%) 21 (36%) 7 (9%) 27% (13% to 40%)z
Postbronchodilator FEV1 z-score
{ 0.75 (0.95) 0.25 (1.14) 0.61 (1.02) 0.08 (0.95) 0.69 (1.02 to 0.36)z
Data are presented as mean (SD) unless stated otherwise.
*P < .05 between all EP children and classmates.
†P < .001 between all EP children and classmates.
zP < .01 between all EP children and classmates.
xSpirometry z-scores adjusting for sex, height, and age derived from Stanojevic et al.36
{Includes 59 EP infants (17 without BPD and 42 with EP) and 79 classmates.
kMann-Whitney test. Results are expressed as median and IQR.
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